153 related articles for article (PubMed ID: 15246174)
1. Blood and bioidentity: ideas about self, boundaries and risk among blood donors and people living with hepatitis C.
Waldby C; Rosengarten M; Treloar C; Fraser S
Soc Sci Med; 2004 Oct; 59(7):1461-71. PubMed ID: 15246174
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for hepatitis C virus infection among blood donors in Israel: a case-control study between native Israelis and immigrants from the former Soviet Union.
Kerzman H; Green MS; Shinar E
Transfusion; 2007 Jul; 47(7):1189-96. PubMed ID: 17581153
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for hepatitis C virus infection among blood donors in northern Thailand.
Thaikruea L; Thongsawat S; Maneekarn N; Netski D; Thomas DL; Nelson KE
Transfusion; 2004 Oct; 44(10):1433-40. PubMed ID: 15383015
[TBL] [Abstract][Full Text] [Related]
4. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
Erhabor O; Ejele OA; Nwauche CA
Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C seroprevalence in accepted versus deferred blood-donor candidates evaluated by medical history and self-exclusion form.
López RA; Romero-Estrella S; Infante-Ramírez L; Méndez-Aquino JS; Berrón-Ruiz P; Morales-Alfaro NA; Vivar R; Carrada E; Rivera-Rendón Mdel R; Sánchez-Guerrero SA
Transfusion; 2004 Sep; 44(9):1344-9. PubMed ID: 15318859
[TBL] [Abstract][Full Text] [Related]
6. Diversity and origin of hepatitis C virus infection among unpaid blood donors in the Netherlands.
van de Laar TJ; Koppelman MH; van der Bij AK; Zaaijer HL; Cuijpers HT; van der Poel CL; Coutinho RA; Bruisten SM
Transfusion; 2006 Oct; 46(10):1719-28. PubMed ID: 17002628
[TBL] [Abstract][Full Text] [Related]
7. Attitudes of Nigerians towards blood donation and blood transfusion.
Okpara RA
Trop Geogr Med; 1989 Jan; 41(1):89-93. PubMed ID: 2763352
[TBL] [Abstract][Full Text] [Related]
8. Current good manufacturing practice for blood and blood components; notification of consignees and transfusion recipients receiving blood and blood components at increased risk of transmitting hepatitis C virus infection ("lookback"). Final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Aug; 72(164):48765-801. PubMed ID: 17886394
[TBL] [Abstract][Full Text] [Related]
9. Understanding non-disclosure of deferrable risk: a study of blood donors with a history of intravenous drug use.
O'Brien SF; Xi G; Yi QL; Goldman M
Transfus Med; 2010 Feb; 20(1):15-21. PubMed ID: 19793079
[TBL] [Abstract][Full Text] [Related]
10. The blood donation experience: self-reported motives and obstacles for donating blood.
Sojka BN; Sojka P
Vox Sang; 2008 Jan; 94(1):56-63. PubMed ID: 18171329
[TBL] [Abstract][Full Text] [Related]
11. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
[TBL] [Abstract][Full Text] [Related]
12. Comparison of demographic and donation profiles and transfusion-transmissible disease markers and risk rates in previously transfused and nontransfused blood donors.
Wang B; Higgins MJ; Kleinman S; Schreiber GB; Murphy EL; Glynn SA; Wright DJ; Nass CC; Chang D; Busch MP;
Transfusion; 2004 Aug; 44(8):1243-51. PubMed ID: 15265131
[TBL] [Abstract][Full Text] [Related]
13. How regular blood donors explain their behavior.
Belda Suárez IM; Fernández-Montoya A; Rodríguez Fernández A; López-Berrio A; Cillero-Peñuela M
Transfusion; 2004 Oct; 44(10):1441-6. PubMed ID: 15383016
[TBL] [Abstract][Full Text] [Related]
14. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
15. Blood safety & prevalence of transfussion transmissible viral infections among donors at the Red Cross Blood Bank in Gondar University Hospital.
Diro E; Alemu S; G/Yohannes A
Ethiop Med J; 2008 Jan; 46(1):7-13. PubMed ID: 18711984
[TBL] [Abstract][Full Text] [Related]
16. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection among Thai blood donors: antibody prevalence, risk factors and development of risk screening form.
Luksamijarulkul P; Thammata N; Sujirarat D; Tiloklurs M
Southeast Asian J Trop Med Public Health; 2004 Mar; 35(1):147-54. PubMed ID: 15272759
[TBL] [Abstract][Full Text] [Related]
18. Risk factors of hepatitis C virus infection in blood donors in Thailand: a multicenter case-control study.
Tanwandee T; Piratvisuth T; Phornphutkul K; Mairiang P; Permpikul P; Poovorawan Y
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S79-83. PubMed ID: 17722300
[TBL] [Abstract][Full Text] [Related]
19. Declining hepatitis C rates in first-time blood donors: insight from surveillance and case-control risk factor studies.
O'Brien SF; Fan W; Xi G; Yi QL; Goldman M; Fearon MA; Infante-Rivard C; Chiavetta JA; Willems B; Pi D; Fast M; Delage G
Transfusion; 2008 May; 48(5):902-9. PubMed ID: 18208409
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus test-seeking motivation in blood donors, São Paulo, Brazil.
Goncalez TT; Sabino EC; Murphy EL; Chen S; Chamone DA; McFarland W
Vox Sang; 2006 Apr; 90(3):170-6. PubMed ID: 16507016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
